Viewpoint on the impact of interferon in the treatment of multiple myeloma: benefit for a small proportion of patients?-Reference-Cited by-同舟云学术

Viewpoint on the impact of interferon in the treatment of multiple myeloma: benefit for a small proportion of patients?

Published:2000-05 Issue:2 Volume:17 Page:77-84
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Bladé J,Esteve J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF02796202.pdf

Reference74 articles.

1. Ludwig CU, Durie BGM, Salmon SE, Moon TE. Tumor growth stimulation in vitro by interferons.Eur J Cancer Clin Oncol 1983;19: 1625–1632.

2. Brenning G. The in vitro effect of leucocyte alfa-interferon on human myeloma cells in a semisolid agar culture system.Scand J Haematol 1985;35: 178–185.

3. Schwabe Met al. Disruption by interferon-alpha of an interleukin 6 growth loop in IL-6 dependent U266 myeloma cells by homologous and heterologous downregulation of the IL-6 receptor alpha and beta chains.J Clin Invest 1994;94: 2317–2325.

4. Einhorn S, Blomgren H, Strander H. Interferon and spontaneous cytotoxicity in man. I. Enhancement of the spontaneous cytotoxicity of peripheral lymphocytes by human leucocyte interferon.Int J Cancer 1978;22: 405–412.

5. Herberman RR, Ortaldo JR, Bonnard GD. Augmention by interferon of human natural antibody-dependent cell-mediated cytotoxicity.Nature 1978;277: 275–277.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progression of monoclonal gammopathy of undetermined significance to multiple myeloma is associated with enhanced translational quality control and overall loss of surface antigens;Journal of Translational Medicine;2024-06-07

2. Activated interferon response from DNA damage in multiple myeloma cells contributes to the chemotherapeutic effects of anthracyclines;Frontiers in Oncology;2024-05-10

3. Bone marrow microenvironment- induced regulation of Bcl-2 family members in multiple myeloma (MM): Therapeutic implications;Cytokine;2023-01

4. Immunological Prognostic Factors in Multiple Myeloma;International Journal of Molecular Sciences;2021-03-30

5. CSNK1α1 mediates malignant plasma cell survival;Leukemia;2014-06-25